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Abstract—Malondialdehyde and acetaldehyde react together with proteins in a synergistic manner and form hybrid
protein adducts, designated as MAA adducts. MAA-protein adducts are composed of two major products whose
structures and mechanism of formation have been elucidated. MAA adduct formation, especially in the liver, has been
demonstrated in vivo during ethanol consumption. These protein adducts are capable of inducing a potent immune
response, resulting in the generation of antibodies against both MAA epitopes, as well as against epitopes on the carrier
protein. Chronic ethanol administration to rats results in significant circulating antibody titers against MAA-adducted
proteins, and high anti-MAA titers have been associated with the severity of liver damage in humans with alcoholic liver
disease. In vitro exposure of liver endothelial or hepatic stellate cells to MAA adducts induces a proinflammatory and
profibrogenic response in these cells. Thus, during excessive ethanol consumption, ethanol oxidation and ethanolinduced oxidative stress result in the formation of acetaldehyde and malondialdehyde, respectively. These aldehydes can
react together synergistically with proteins and generate MAA adducts, which are very immunogenic and possess
proinflammatory and profibrogenic properties. By virtue of these potentially toxic effects, MAA adducts may play an
important role in the pathogenesis of alcoholic liver injury. © 2002 Elsevier Science Inc.
Keywords—Acetaldehyde, Malondialdehyde, Protein-adducts, Liver injury, Oxidative stress, Autoimmunity, Liver
fibrosis, Free radicals

INTRODUCTION

molecular mechanisms by which ethanol exhibits its
hepatotoxic effects remain unclear. Because high levels
of reactive aldehydes are generated in the liver during
ethanol metabolism, aldehyde-derived modification of
proteins (or other macromolecules) has been proposed as
a key event leading to liver injury [1– 4].
Ethanol oxidation in the hepatocyte results in the
formation of acetaldehyde. Furthermore, there is also
considerable evidence that chronic ethanol consumption
induces oxidative stress and lipid peroxidation in the
liver [5,6], resulting in the generation of additional reactive aldehydes, especially malondialdehyde (MDA) and
4-hydroxy-2-nonenal (HNE) [7,8]. All of these aldehydes exhibit reactivity with proteins [9 –12], and the
presence of acetaldehyde-, MDA-, and HNE- protein
adducts have been detected in livers of ethanol-fed rats,
micropigs, and humans [2,13,14]. Although these aldehydes alone are capable of adduct formation with proteins, the situation in the liver during ethanol metabolism
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is such that these aldehydes co-exist and may influence
each other’s reactivity with proteins. In studies exploring
this possibility [15], our laboratory has demonstrated that
MDA and acetaldehyde react in concert with proteins in
a synergistic manner. The presence of both aldehydes
strikingly increases each other’s binding to proteins and
generates hybrid adducts that are clearly different from
those adducts formed by either aldehyde alone. These
composite MDA-acetaldehyde-protein adducts have
been designated as “MAA adducts.” MAA adducts are
relatively stable products and have been structurally
characterized. In addition, MAA adducts appear to induce potent, specific immune responses and possess
other unique biological properties relevant to cell injury.
Therefore, the focus of this report will be to describe the
chemistry of MAA adduct formation and to provide
information concerning the functional consequences of
MAA adducts as they relate to liver injury.
CHEMISTRY OF MAA ADDUCTS

Our initial studies [15] showed that when MDA and
acetaldehyde were incubated together with proteins, a
marked stimulation of binding of both aldehydes to proteins occurred compared to conditions examining the
binding of each aldehyde in the absence of the other. For
example, when the model protein, bovine serum albumin
(BSA), was incubated in the presence of both MDA and
acetaldehyde, MDA caused a marked and concentrationdependent increase in the stable binding of acetaldehyde
to BSA. A 13-fold stimulation of binding was observed
with equal molar concentrations of the aldehydes, increasing to over 32-fold at a 4-fold molar excess of
MDA. Likewise, the presence of acetaldehyde also stimulated the binding of MDA to proteins. This stimulation
of aldehyde binding to proteins resulted in a reaction
mixture that exhibited highly fluorescent properties.
Since these highly fluorescent products were absent
when equimolar concentrations of acetaldehyde alone or
MDA alone were allowed to react with proteins, it appeared that new and distinct products were generated.
These hybrid adducts composed of MDA and acetaldehyde were designated as MAA adducts [15].
Upon the basis of chemical analysis [16,17], NMR
spectroscopy [17], and immunochemical analysis [16], it
appears that two major products result from the reaction
of MDA and acetaldehyde with proteins, and these structures are depicted in Fig. 1. One adduct is a highly
fluorescent, cyclic product composed of two molecules
of MDA and one molecule of acetaldehyde and was
identified as the 4-methyl-1,4-dihydropyridine-3,5-dicarbaldehyde derivative of an amino group (MDHDC
adduct). The other adduct (nonfluorescent) is a 1:1 adduct of MDA and acetaldehyde and was identified as the

Fig. 1. Structures of MAA-protein adducts.

2-formyl-3-(alkylamino)butanal derivative of an amino
group (FAAB adduct).
Another important aspect of MAA adduct chemistry
is the reaction mechanism that describes the generation
of MAA-protein adducts. Our previous studies showed
that when MDA and acetaldehyde were allowed to react
with proteins, formation of the FAAB (nonfluorescent)
adduct preceded the formation of the MDHDC (fluorescent) adduct [16,17]. These findings suggested that the
FAAB adduct may serve as a precursor for the generation of the MDHDC adduct. In a recent study [18], it was
shown that the first step in the reaction scheme involves
the reaction of one molecule of MDA and one of acetaldehyde with an amino group of a protein to generate
the FAAB adduct. The other initial step of the overall
reaction scheme is the reaction of MDA with an amino
group to form a MDA Schiff base (MDA-enamine).
After the generation of these two intermediates, the
FAAB moiety is transferred to the nitrogen of the MDAenamine followed by ring closure to produce the
MDHDC adduct. It is important to note that the MDHDC
product was formed on the nitrogen of the MDA-enamine. For efficient transfer of the FAAB moiety to the

MAA adducts and liver injury

enamine, evidence indicates that these two intermediates
likely must be in positions on the protein of close proximity to each other.
IMMUNE RESPONSES TO MAA ADDUCTS

Immunogenicity of MAA adducts
Classical immunization experiments demonstrated
that MAA-protein adducts were capable of inducing an
antibody response [15]. Further studies showed that
MAA adducts could induce an antibody response without the use of adjuvants [19], indicating the potent immunogenicity of these adducts. The antibodies generated
were able to recognize and bind either MAA epitopes or
epitopes of the unmodified carrier protein [19]. In lower
immunizing doses, the antibody response was mainly to
the carrier protein; whereas, larger doses induced strong
anti-MAA responses. These antibody responses were
observed for several carrier proteins that were MAA
adducted [19]. Additional studies demonstrated that the
antibodies that recognized MAA epitopes were exclusively against the cyclic, fluorescent adduct (i.e.,
MDHDC adduct) and not against the nonfluorescent (i.e.,
FAAB) adduct [16].
Initial studies designed to determine the mechanism
of the potent immunogenicity of MAA adducts suggested that scavenger receptors, located at the cell surface of peritoneal macrophages or other antigen processing cells, are able to bind and endocytose, process, and
present MAA-adducted proteins [19]. This increase in
antigen presentation induced by the MAA adduction of
proteins would then increase T-helper cell proliferation
and activation, ultimately resulting in the enhanced ability of B-cells to produce specific antibodies. Recent
support for this mechanism was obtained by investigating the induction of immune responses to MAA adducts
in scavenger receptor-A knockout (SRA-KO) mice [20].
These studies showed that the immune response to MAA
adducts was attenuated but not eliminated in these
knockout mice, suggesting that scavenger receptor-A
plays a prominent role, but that other receptors (or other
events) may also contribute to generating immune responses to these altered proteins.
Antibodies against MAA adducts in ethanol-fed rats
Chronic ethanol administration to rats has been shown
to result in significant circulating antibody titers against
MAA-adducted proteins [21]. Competitive inhibition assays demonstrated that antibodies against MAA-modified proteins in the ethanol-fed rats recognized a specific
MAA epitope, which was the MDHDC adduct. Additional characterization of the circulating anti-MAA anti-
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bodies in the ethanol-fed rats showed that these antibodies were also capable of reacting with MAA-modified
proteins from rat liver, including cytosolic, microsomal,
and plasma membrane proteins. Further examination of
plasma immunoreactivity indicated that ethanol feeding
generated antibodies that recognized not only the specific
MDHDC epitope on rat liver proteins but also epitopes
on the unmodified (native) protein fractions. It also appeared that the magnitude of the increase in the immune
response in the ethanol-fed animals was the greatest for
the plasma membrane proteins [21]. The mechanism for
the increased generation of antibodies to unmodified
(native) rat liver proteins in the ethanol-fed rats is unknown, but could be related at least in part to MAA
modification of rat liver proteins during long-term ethanol ingestion. As discussed previously, MAA adduction
specifically targets proteins for antigen processing and
presentation, eventually leading to increased and specific
immune responses to both the MDHDC epitope and
carrier (native) proteins.

Antibodies against MAA adducts in humans
In a recent study [22], circulating antibodies against
MAA adducts were evaluated in patients with alcoholinduced hepatitis or cirrhosis, in patients with non-alcohol-induced liver disease, in heavy drinkers without liver
damage, and in healthy controls. The results of this study
showed that levels of immunoglobulin G (IgG) that reacted with MAA-modified proteins was significantly elevated in the patients with alcohol-induced hepatitis or
cirrhosis compared to subjects in the other three groups.
The specific MAA epitope that was recognized by the
elevated IgGs was once again the MDHDC adduct. Furthermore, in the alcoholic liver disease group, patients
with moderate or severe liver injury displayed significantly higher anti-MAA IgG titers compared with patients with mild liver damage, indicating a correlation of
circulating anti-MAA antibody titer to the severity of
liver damage.
IN VIVO FORMATION OF MAA ADDUCTS DURING
ETHANOL CONSUMPTION

Although the characterization of the chemistry of
MAA-protein adducts is important, verification that these
adducts are generated during ethanol consumption in
vivo represents a key element in evaluating the role of
MAA adducts in alcoholic liver injury. In this regard,
antibodies against MAA adducts, specifically the
MDHDC epitope, as previously discussed, have been
detected both in rats [21] and humans [22] chronically
consuming alcohol, implying that this adduct formed on
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endogenous proteins and stimulated antibody production.
Immunoanalysis, employing an affinity purified polyclonal antibody against the MDHDC epitope, as well as
a monoclonal antibody to this epitope [16,19], directly
confirmed the presence of MAA-modified proteins in
livers from ethanol-fed rats (Lieber-DeCarli diet) [15].
Although the presence of the MDHDC adduct in livers
from ethanol-fed rats was demonstrated by this study, the
formation of the FAAB adduct could not be ascertained
because a suitable antibody against the FAAB adduct
was unavailable. However, recently our laboratory has
obtained indirect evidence that FAAB adducts might also
be formed in the liver during ethanol consumption. In
this study [18], it was shown that in vitro incubation of
liver homogenates, obtained from ethanol-fed rats, with
exogenously added MDA markedly increased the levels
of MDHDC-protein adducts. Because the FAAB adduct
has been shown to be a precursor in the formation of the
MDHDC adduct upon reaction with a MDA-enamine
[18], these findings would strongly suggest the presence
of a pool of FAAB-protein adducts in the livers of
ethanol-fed animals. Furthermore, these results strongly
suggest that MDHDC-protein adduct formation in vivo
may very well proceed by the same reaction scheme that
describes in vitro formation of this adduct.
Worrall and coworkers have also demonstrated the
formation of MAA adducts in rats fed the Lieber-DeCarli
ethanol containing diet. MAA adducts were detected in
the livers as early as 2 weeks of feeding ethanol and
reached maximum levels after 6 weeks [23]. MAA adduct formation with plasma proteins was shown after 6
weeks of ethanol administration, although the degree of
modification was less than that observed for liver proteins [23]. In addition, in the same study circulating
antibodies against MAA proteins in the ethanol-fed rat
were also identified. In a subsequent study, Worrall et al.
[24] were able to demonstrate the presence of MAA
adducts in cardiac muscle obtained from ethanol-fed rats.
It appears that in all cases referred to above that the
major MAA adduct detected in these studies was again
the MDHDC adduct.
In summary, several studies have demonstrated the
formation of MAA adducts, especially in the liver, during ethanol consumption. Thus, it appears that in addition to acetaldehyde, MDA, and HNE adducts, MAAadducts represent another important aldehyde-derived
modification of proteins elicited by in vivo ethanol metabolism. In fact, it could be argued that because acetaldehyde and MDA can bind in a synergistic manner to
proteins, conditions in the liver during ethanol oxidation
would favor MAA adduct formation over the formation
of the individual aldehyde adducts; and therefore, MAA
adducts may very well represent the major aldehydic
adduct.

FUNCTIONAL CONSEQUENCES OF MAA ADDUCTS AND
THEIR ROLE IN LIVER INJURY

An important aspect regarding the relevance and significance of MAA adducts, in addition to demonstrating
their formation during ethanol consumption, is the biological effects of these adducts, especially as they relate
to liver injury and to cell injury in other organs. Recent
studies have described some interesting and unique biological properties of MAA adducts which may be relevant to their role in inducing liver damage, and the
findings from these studies will be summarized in this
section.
Influence of MAA adducts on the immune system as it
relates to liver injury
Many of the clinical features of alcoholic liver disease
suggest that immune effector mechanisms may be contributing to liver tissue damage, and many earlier studies
have implicated immune factors in the pathogenesis of
alcoholic liver disease [25]. As previously discussed in
an earlier section of this report and reported in detail in
a recent article summarizing the proceeding of a recent
workshop at the 2000 ISBRA Meeting in Yokohama,
Japan [20], MAA adducts induce a potent immune response, which may represent an important immunotoxic
event relevant to the pathogenesis of liver injury. The
following experimental findings are consistent with this
hypothesis: (i) MAA adducts induce antibody responses
against MAA epitopes as well as to epitopes on the
carrier protein including “self” epitopes in the case of
MAA adducted liver and plasma proteins; (ii) These
immune responses occur in the absence of adjuvant, are
rapid in onset, and appear to be restricted to the production of the IgG1 isotype; (iii) Circulating antibodies
against MAA adducts have been observed in ethanol-fed
animals and in humans with alcoholic liver disease. In
the latter case, antibody titers correlated with the severity
of liver injury. In addition, the presence of circulating
antibodies to “self” proteins (perhaps generated as a
result of MAA adduction) has also been reported in
ethanol consuming animals; (iv) MAA modification of
the hepatitis B antigen (in the absence of adjuvant)
enhanced the induction of a cytotoxic T-cell response.
Overall, these findings suggest that MAA adducts
could contribute to the development of immunotoxic
reactions that could induce alcoholic liver injury by
stimulating the production of antibodies and/or T-cells
against MAA epitopes (neoantigens) and/or autoantigens
(self-epitopes). Therefore, the MAA adduction of proteins could be a mechanism by which harmful immunogens are generated and trigger destructive immune responses targeting liver cells.

MAA adducts and liver injury

Effects of MAA adducts on hepatic endothelial and
stellate cells
The in vitro incubation of isolated liver endothelial
cells (LECs) with MAA adducts has been shown to
stimulate the secretion of several cytokines and chemokines, including tumor necrosis factor-␣, monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-2 (MIP-2) [20]. Additionally, the
exposure of LECs to MAA adducts upregulated the expression of adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1), L-selectin, and P-selectin
[20]. MAA adducts also stimulated the secretion of fibronectin by LECs [20]. This latter finding is important
because fibronectin has been implicated in the activation
of hepatic stellate cells (HSCs), the principal cell type in
the liver responsible for the increased deposition of extracellular matrix proteins that characterizes fibrosis and
cirrhosis [26].
In addition to activating LECs, MAA adducts also
directly affect the function of HSCs. Exposure of isolated
HSCs to MAA adducts resulted in a dose- and timedependent increase in the secretion of the two chemokines, MCP-1 and MIP-2, and in the upregulation of
ICAM [27]. Further studies showed that MAA adducts
also increase the secretion of urokinase-type plasminogen activator (uPA) via a protein kinase C- (PKC) dependent pathway [28].
These MAA-induced effects on LECs and HSCs appear to be mediated by MAA adducts binding to surface
receptors on these cells and initiating signaling cascades
[20,28]. Although the specific receptors mediating these
effects have not been identified as yet, preliminary studies indicate that they may be members of the scavenger
receptor family [20]. Overall, these studies strongly suggest that the activation of LECs and HSCs by MAAmodified proteins may be one mechanism by which
proinflammatory and profibrogenic processes are initiated and may play a significant role in the development
and/or progression of liver injury.
PERSPECTIVES AND SUMMARY

MAA-protein adducts appear to be a major aldehydic
adduct that forms in the liver and other organs during
chronic alcohol consumption. These adducts induce a
potent immunogenic response and possess proinflammatory and profibrogenic properties. Therefore, upon the
basis of what is known about the chemistry of MAA
adducts and their biological actions, the following series
of events describing the role of MAA adducts in the
pathogenesis of alcoholic liver injury is proposed: in the
early stages of ethanol consumption, nonfluorescent
MAA adduct (i.e., FAAB adduct) formation would be
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favored because acetaldehyde concentrations would
likely exceed those of MDA. This situation would result
in a pool of FAAB adducts in the liver. With more
prolonged ethanol intake, oxidative stress and lipid peroxidation would occur, resulting in elevated MDA levels, which would be available to generate Schiff base
adducts (MDA-enamines) with protein amino groups.
The Schiff bases would be available to accept the transfer of the FAAB moiety from the already preformed pool
of these nonfluorescent adducts, forming the fluorescent
MAA adduct (i.e., MDHDC adduct). This adduct, which
has been shown to be very immunogenic and to possess
proinflammatory and profibrogenic properties, could by
virtue of these potentially toxic effects contribute to the
pathogenesis of alcoholic liver injury.
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ABBREVIATIONS

BSA— bovine serum albumin
FAAB—2-formyl-3-(alkylamino)butanal
HNE— 4-hydroxyl-2-nonenal
HSCs— hepatic stellate cells
ICAM-1—intercellular adhesion molecule-1
IgG—immunoglobulin G
LECs—liver endothelial cells
MAA—malondialdehyde-acetaldehyde
MDA—malondialdehyde
MDHDC— 4-methyl-1,4-dihydropyridine-3,5-dicarbaldehyde
MCP-1—macrophage chemotactic protein-1
MIP-2—macrophage inflammatory protein-2
PKC—protein kinase C
uPA— urokinase-type plasminogen activator

